Feedback / Questions
SHR-1802 - Jiangsu Hengrui Pharma
famitinib (SHR 1020) - Jiangsu Hengrui Pharma
AiRuiKa (camrelizumab) - HLB Bio Group
http://clinicaltrials.gov/ct2/show/NCT05208177
Aug 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next